Sarah Hoffe MD

Dr. Sarah Hoffe is the Section Head of GI Radiation Oncology at Moffitt Cancer Center and joined the faculty in 2006. She is an Associate Member at Moffitt and Associate Professor in the University Of South Florida Morsani College Of Medicine’s Department of Oncologic Sciences. Dr. Hoffe’s research and clinical interests include cancers of the esophagus, stomach, liver, pancreas, bile duct, rectum, colon, anus, as well as neuroendocrine cancers. She has experience with advanced radiation therapy techniques such as intensity modulated radiation therapy (IMRT), three dimensional conformal radiation therapy (3D-CRT), stereotactic body radiation therapy (SBRT), radioembolization, and image guided radiation therapy (IGRT) using endoscopically implanted fiducial markers. At Moffitt, she works closely with her multidisciplinary colleagues in GI surgery, medical oncology, gastroenterology, radiology and pathology to develop new treatments for patients with GI cancers.

She is very interested in 4D PET/CT imaging and works with the PET/CT committee at Moffitt In addition to GI cancers and radiation oncology, Dr. Hoffe is also interested in the integration of novel patient engagement technologies that will improve the patient experience, such as piloting novel virtual reality tools. After completing her undergraduate studies at Brown University, Dr. Hoffe received her MD degree from the University of Vermont. She then completed a transitional year internship at Mayo Clinic Jacksonville followed by residency in radiation oncology at Duke University Medical Center and Memorial Sloan-Kettering Cancer Center and fellowship at MD Anderson Cancer Center. Dr. Hoffe devotes a significant portion of her time to the promotion of medical education. Nationally, she is the Director of eContouring at ASTRO, is on the advisory board for the Contemporary Radiation Oncology Journal, and is a contributor to the Up to Date Online educational site, having co-authored the section on bone metastases. She serves on the ASTRO Education Committee and the HIMSS connected patient committee.